Evaluating non-randomised intervention studies - NIHR Health ...

More documents

Recommendations

Info

150Author Review IV type b Topic Total RCTs NRS Other Type of QA Tool QA results dtype atool cWells-Parker, MA Behav Drink/drive offenders 194 NS NS 0 S Author’s own No. scoring in certain1995 129 rangesWingood, 1996 202 Nar Behav HIV/AIDS 7 5 2 0 C Modified Oakley, 1994 128 Itemised; NarWitlin, 1998 381 Nar Pharm Pre-eclampsia and 18 14 4? 0 LoE US Task Force, 1989 378 OS; level of evidenceEclampsiaWright, 1995 203 Nar Other Obstructive sleep apnoea 23 1 22 0 C Author’s own NarAppendix 6a MA, meta-analysis; Nar, narrative.b Rehab, rehabilitation; Vacc, vaccination; Diet, dietary; Pharm, pharmaceutical; Surg, surgery; Org, organisation; Educ, education; Mixed, several interventions; Psych, Psychiatry;Alt med, alternative medicine; Behav, behavioural therapy; Physio, physiotherapy; Psych-ed, psychoeducational; H promo, health promotion; Occ ther, occupational therapy;other, other types of intervention; Prim prev, primary prevention; Exerc, exercise; Pall care, palliative care.c LoE, Levels of evidence; S, Scale; C, checklist; NR, not reported.d Itemised, itemised per study; Nar, narrative description; OS, overall score.e NIDDM = non-insulin-dependent diabetes mellitus.
Health Technology Assessment 2003; Vol. 7: No. 27Appendix 7Results of identified systematic reviews151© Queen’s Printer and Controller of HMSO 2003. All rights reserved.
Page 1 and 2:
Health Technology Assessment 2003;
Page 3 and 4:
Evaluating non-randomisedinterventi
Page 5 and 6:
Page 7:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17:
Page 21 and 22:
Page 23 and 24:
© Queen’s Printer and Controller
Page 25 and 26:
Page 27 and 28:
© Queen’s Printer and Controller
Page 29 and 30:
Page 31 and 32:
Page 33:
Page 36 and 37:
Evaluation of checklists and scales
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
32TABLE 8 Details of top 60 quality
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
38TABLE 10 Other domains: reporting
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Use of quality assessment in system
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Empirical estimates of bias associa
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Empirical evaluation of the ability
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
70TABLE 22 Comparison of concurrent
Page 84 and 85:
Page 86 and 87:
74TABLE 26 Comparison of methods of
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
80TABLE 33 Hypothetical example dem
Page 94 and 95:
82TABLE 34 Hypothetical example dem
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Discussion and conclusions88histori
Page 102 and 103:
Discussion and conclusions90For exa
Page 104 and 105:
Discussion and conclusionsNon-rando
Page 107 and 108:
Page 109 and 110:
Page 111 and 112: Health Technology Assessment 2003;
Page 121: Health Technology Assessment 2003;
Page 124 and 125: Appendix 1data)) or (non-random$ or
Page 126 and 127: Appendix 2AuthorYearENDARESourcePub
Page 128 and 129: Appendix 2Author:Accession No:Endno
Page 130 and 131: Appendix 20 0 00Additional outcomes
Page 132 and 133: Appendix 2Endnote NoWas CMA conside
Page 134 and 135: 122AuthorOrigin aModified toolTool
Page 148 and 149: Appendix 4136DuRant, 1994 99The typ
Page 155 and 156: © Queen’s Printer and Controller
Page 161: © Queen’s Printer and Controller
Page 185: Health Technology Assessment 2003;
Page 188 and 189: Health Technology Assessment Progra
Page 190: Health Technology Assessment Progra
show all

Evaluating non-randomised intervention studies - NIHR Health ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?